U.S. Industrial REITs Stock News

NasdaqGS:AVXL
NasdaqGS:AVXLBiotechs

Why Anavex Life Sciences (AVXL) Is Down After an EMA Setback for Its Alzheimer’s Drug Application

Anavex Life Sciences recently reported that the European Medicines Agency’s Committee for Medicinal Products for Human Use issued a negative trend vote on the company’s Marketing Authorisation Application for blarcamesine, an investigational oral treatment for early Alzheimer’s disease. This outcome prompts Anavex to seek a re-examination and submit additional biomarker data, while maintaining regulatory dialogue with both European and U.S. health authorities. We'll explore how this...
NasdaqGM:NEXN
NasdaqGM:NEXNMedia

Nexxen (NEXN) Reduces 2025 Guidance After Earnings—Is Market Optimism Outpacing Programmatic Reality?

Nexxen International Ltd. recently reported third quarter 2025 earnings, showing sales of US$94.79 million and net income of US$4.21 million, both compared to the same period last year. Despite increased year-to-date sales and improved nine-month net income, the company lowered its full-year 2025 financial guidance, highlighting shifts in its programmatic revenue outlook. We'll examine how Nexxen's reduced full-year earnings guidance alters the company's investment narrative and future...
OTCPK:ABXX.F
OTCPK:ABXX.FSoftware

A Look at Abaxx Technologies (OTCPK:ABXX.F) Valuation After ARTEX Partnership and Enwex German Wind Futures Launch

Abaxx Technologies (OTCPK:ABXX.F) has been in the spotlight following two key moves: a partnership with ARTEX AG to modernize asset trading and the launch of the Enwex German Wind Futures contract. These developments highlight Abaxx's expanding global reach and focus on market infrastructure innovation. See our latest analysis for Abaxx Technologies. After a year of eye-catching developments, Abaxx Technologies is drawing more attention from growth-minded investors. The 237.5% year-to-date...
NasdaqCM:FTCI
NasdaqCM:FTCIElectrical

A Look at FTC Solar’s Valuation Following Strong Q3 Results, Strategic Deals, and Guidance for Growth

FTC Solar, a US-based solar technology firm, delivered third quarter 2025 earnings that outperformed market forecasts and sent the stock higher. The company’s revenue jumped sharply year over year, and it returned to gross profit positivity. See our latest analysis for FTC Solar. FTC Solar’s upbeat third-quarter results have helped fuel a major reversal in sentiment. The stock is now at $10.43 after surging more than 80% year-to-date. While one-day swings remain sharp, the recent run is...